Abbreviations used BMMC: Bone marrow-derived mast cell DARPin: Designed ankyrin repeat protein FACS: Fluorescence-activated cell sorting RU: Relative units SIT: Allergen-specific immunotherapy the population in developed countries. 1, 2 The principal effector mechanism of IgE is mediated by the high-affinity IgE receptor (FcεRI), which is expressed by a number of cells, including mast cells and basophils. Free IgE binds to these cells and activates FcεRI on cross-linking by allergen, inducing release mediators (histamines and others) that cause allergic symptoms. 3 A number of possibilities exist to treat IgE-mediated allergies. Most currently used therapies consist of symptomatic medications, such as antihistamines or corticosteroids. The only disease-modifying therapy available is allergen-specific immunotherapy (SIT), whereby patients are treated with multiple doses of allergen, changing the immune system in a way to tolerate the allergens better. 4, 5 Even though there is an ongoing discussion about the most critical effector mechanism or mechanisms for this state of enhanced ''tolerance,'' it is clear that induction of allergen-specific IgG correlates with reduced symptoms and is taken as evidence for successful therapy. 6, 7 Allergen-specific IgG antibodies can improve allergic symptoms in a number of ways. The most important mechanisms are allergen neutralization and engagement of the inhibitory Fc receptor (FcgRIIb). Allergen neutralization blocks binding of allergen to FcεRI-bound IgE and therefore follows the classical path of neutralizing antibodies blocking, for example, viruses from engaging their receptors. IgG antibodies need to block essentially all epitopes available for IgE binding on the allergen to be effective at neutralizing the allergen. Therefore this mechanism follows the rules of competitive inhibition. [8] [9] [10] Antibodies engaging the inhibitory receptor block cellular activation by triggering FcgRIIb, leading to recruitment of the SH2 domain-containing inositol 59-phosphatase, which in turn dephosphorylates signal transduction molecules below FcεRI. Such inhibitory IgG antibodies also must bind the allergen, but it is not necessary to block all available epitopes. Indeed, a single IgG antibody might be sufficient to block polyclonal IgE antibodies of multiple specificities. 6, 11 Thus, in contrast to neutralizing antibodies, which act as competitive inhibitors, inhibiting IgG antibodies are better compared with noncompetitive enzyme inhibitors. 3, 12, 13 The role of antibody affinity in blocking allergen activity is poorly understood. As outlined above, however, one might expect a different effect of affinity for allergen neutralization versus engagement of FcgRIIb because affinity is more important for competitive versus noncompetitive inhibitors. To test this hypothesis, we used 2 well-described high-affinity antibodies for Fel d 1, the major allergen in cats, and generated low-affinity versions by reversing affinity maturation and mutating variable regions back to their germline sequences. Using in vitro and in vivo models, we demonstrated that high-affinity antibodies block cellular activation through allergen neutralization and engagement of FcgRIIb, whereas low-affinity antibodies do not neutralize the allergen but are still effective through the inhibitory mechanism. Hence, despite inefficient allergen binding, antibodies with low IgG affinity might still efficiently block allergic responses in vivo.
METHODS Mice
Female BALB/cOlaHsd mice were purchased from Envigo (London, United Kingdom) at the age of 5 to 7 weeks.
Cloning, expression, and purification of germline monoclonal anti-Fel d 1 IgG 2a
Cloning. Two Fel d 1 IgG 2a s (A044 and F127) that recognized different epitopes on Fel d 1 were kindly provided by Dr Franziska Zabel and produced, as described previously. 4 Briefly, BALB/c mice were immunized with 50 mg of rFel d 1 coupled to virus-like particles derived from the bacteriophage Qb. Fel d 1-specific memory B cells were isolated by using fluorescence-activated cell sorting (FACS). Sorted B cells were used to generate a random combinatorial antibody library that was screened by using the Sindbis-based mammalian cell display, 14 which allowed isolation of the 2 Fel d 1 IgG 2a antibodies. Sequences of the variable regions from IgG 2a A044 and F127 were aligned with the germline genomic database available at http://www. imgt.org to clone germline sequences. Germline sequences of the variable regions from IgG 2a A044 and F127 were synthesized by GeneArt (Thermo Fisher, Waltham, Mass), with additional restriction cutting sites (XhoI and ApaI for the light chain and SacI and EcoRI for the heavy chain). Variable regions of light chains from each epitope were digested with XhoI and ApaI and cloned into the light chain plasmid, which contains the constant region of the kappa chain. Similarly, variable regions of heavy chains were inserted in front of the gamma constant region in the heavy chain plasmid through SacI and EcoRI. Afterward, the new constructed heavy and light chain plasmids were digested with AscI, PacI for heavy chain and with NheI, PmeI for the light chain. The fragments were then cloned into the final expression plasmid (pCB15-GL) under 2 independent pCMV promoters (see Fig E1 in this article's Online Repository at www.jacionline.org).
Recombinant monomeric and dimer Fel d 1 proteins were generated, as previously described. 4 Briefly, a cDNA that encoded a covalent dimer of chains 2 and 1 of Fel d 1, spaced by the 15-amino-acid linker (GGGGS)x3, was obtained by using PCR. This amplicon was cloned into a modified version of pET-42a, leading to addition of the sequence LEHHHHHHGGC at the C-terminus of the covalent dimer.
Expression. pCB15-GL, comprising both heavy and light chain germline sequences, was transfected on HEK293T cells. Briefly, 5 3 10 7 cells were seeded in a T75 flask in complete growth medium (Dulbecco modified Eagle medium [catalog 11965084; Gibco, Carlsbad, Calif] supplemented with 10% FCS and 1% penicillin and streptomycin) 1 day before transfection. The DMEM complete growth medium was changed to serum-free DMEM medium before transfection. Fifteen micrograms of pCB15-GL plasmid DNAwas mixed with 45 mL of polyethylenimine and incubated at room temperature for 15 minutes, which was added to the cells dropwise. Serum-free medium was changed to DMEM complete growth medium 6 hours after transfection and collected 24, 48, and 69 hours after transfection.
Purification. Germline IgG 2a in supernatants from transfected cells was purified by using the HiTrap Protein G HP column (catalog 7-0402-01; GE Healthcare, Fairfield, Conn) with the € AKTA Pure protein purification system (GE Healthcare). Expression and purification of germline antibodies were checked on 10% SDS-PAGE.
ELISA of germline A044 IgG 2a and F127 IgG 2a . ELISA plates were coated with 1 mg/mL mouse Fel d 1 dimer. Purified mature and germline antibodies A044 IgG 2a and F127 IgG 2a were first added to the wells at increasing concentrations diluted in PBS/casein. Bound antibodies were detected by using horseradish peroxidase-conjugated anti-mouse IgG 2a (Southern Bioscience, Birmingham, Ala). The reaction was stopped after 5 minutes with 1 mol/L sulfuric acid, and absorbance was measured at OD 450 nm in a standard ELISA reader (BioTek Microplate Readers; BioTek, Winooski, Vt).
Bone marrow-derived mast cells
The method for generating bone marrow-derived mast cells (BMMCs) has been described previously. 4 Generally, 5 3 10 8 bone marrow cells were cultured in complete RPMI medium supplemented with recombinant mouse stem cell factor (50 ng/mL; R&D Systems, Minneapolis, Minn) and recombinant mouse IL-3 (30 ng/mL; R&D Systems). The final differentiation status of BMMCs was determined by measuring c-Kit expression (allophycocyanin-anti-mouse c-Kit; BD, Franklin Lakes, NJ) and FcεRI levels (phycoerythrin-anti-mouse FcεRI; eBioscience, San Diego, Calif) by using flow cytometry 4 to 5 weeks after culture.
Flow cytometry
BMMCs were washed with FACS buffer (2% FBS in PBS) and blocked for 1 hour with mouse anti-Fel d 1 IgG 2a (5 mg/mL) at 48C. Afterward, BMMCs were washed twice with FACS buffer and stained with fluorescein isothiocyanate-anti-mouse IgG 2a (clone R19-15; BD) antibodies for 30 minutes at 48C. Cells were then washed twice with FACS buffer and measured by using flow cytometry.
Affinity measurement using surface plasmon resonance
Measurements were performed on a Biacore X100 instrument (GE Healthcare Europe GmbH, Freiburg, Germany). We used HBS-EP1 
Epitope mapping
To determine whether the germline anti-Fel d 1 antibodies have kept the same epitope specificities as the mature antibodies, we analyzed binding epitopes of the germline antibodies on surface plasmon resonance. Monomeric Fel d 1 was immobilized onto a CM5 sensor chip to a capture level of 1000 RU. The surface was first saturated with 2 serial injections of each parental mature antibody until most of the epitopes were covered and the sensorgram reached a threshold value. The germline and opposite parental antibodies were then injected once at concentrations of 500 and 50 nmol/L, respectively, for 2 minutes at a flow rate of 30 mL/min.
BMMC degranulation
The degree of BMMC degranulation was determined by measuring b-hexosaminidase release. Briefly, BMMCs were loaded with 40 mg/mL . ODs at 405 nm were determined as readout. The degree of degranulation was calculated as follows:
Ear prick test
Mice were given intravenous injections of 10 mg of mouse IgE (A044 or F127 and/or 100 mg IgG 2a ; clone A044, A044GL, F127, or F127GL). Twenty-four hours later, each mouse was given an intravenous injection of 200 mL of Evans blue dye (0.5% in PBS); designed ankyrin repeat proteins (DARPins) against mouse FcgRIIb receptor (kindly provided by Dr Alex Eggel 15 ) were used for blocking the receptor by means of local subcutaneous injection on the ears 10 minutes before the ear prick. Twenty-five minutes later, after administration of Evans blue dye, 1 drop of Fel d 1 dimer (200 mg/mL) was placed on the outer ear skin of anesthetized mice after pricking the ears with a needle. Mast cell degranulation was determined 45 minutes after the ear prick and quantified based on the degree of dye extravasation. Briefly, mice were killed, and ears were collected. Dye was extracted from the collected ears by means of digestion with 150 mL of 1 mol/L KOH overnight at 378C. The next day, 150 mL of 5% H 3 PO 4 in acetone was added, and samples were centrifuged. Supernatants were collected and measured at an OD of 595 nm to quantify the extracted dye.
Passive systemic anaphylaxis
Mice were sensitized passively with 10 mg of Fel d 1-specific IgE A044 by means of intravenous tail vain injection. The next day, either 100 mg of IgG 2a (A044 or germline A044 or F127 or germline F127) or 100 mg of IgG 2a 
RESULTS

Binding properties of Fel d 1-specific germline antibodies
Two low-affinity Fel d 1-specific germline antibodies, IgG 2a A044 and F127, were generated to investigate the role of antibody affinity in blocking allergen activity. To this end, Fab regions of mature IgG 2a A044 and F127 antibodies 7 were aligned with the germline sequences of both heavy and light variable chains to determine the origins of V, D, and J genes before somatic recombination (Table I ). The germline Fabs were then cloned into mouse IgG 2a expression vector (see Fig E1) and expressed in 293HEK cells. The purity and size of the germline antibodies after protein G purification were determined by using SDS-PAGE and compared with the parental mature antibodies. Kinetic parameters of germline antibodies (germline A044 and germline F127) were assessed by using surface plasmon resonance and compared with those of mature antibodies (A044 and F127, Table II ). The mature antibody F127 displayed higher association and lower off-rates than germline F127 on both monomeric and dimeric Fel d 1 (Table II) , resulting in more than 100 times lower affinity for the germline antibody compared with the mature one. Similarly, compared to the mature antibody A044, the germline antibody A044 exhibits a 100 times lower affinity for monomeric and dimeric Fel d 1 (Table II) .
The kinetic parameters for germline A044 could not be measured in the same manner as the others for technical reasons. To confirm that germline antibodies recognized the same epitope as the parental mature antibodies, we performed epitope mapping on a chip exhibiting immobilized monomeric Fel d 1. The chip surface was saturated with either mature A044 or F127 antibodies until the sensorgram reached a maximal response (Fig 1) . Subsequently, either germline A044 or F127 antibodies, as well as mature antibodies for control purposes, were injected for an additional 2 minutes. As expected, both germline antibodies were no more able to bind to immobilized Fel d 1 when the chip was saturated with the corresponding mature antibodies, indicating that they recognize the same epitope as their corresponding parental mature antibodies. In contrast, germline antibodies were able to bind, although at a low level, if Fel d 1 was presented by the other parental mature antibody.
Fel d 1-specific germline IgG 2a inhibits BMMC degranulation in vitro
It has been shown previously that IgG antibodies should bear an affinity high enough to compete with IgE for inhibiting cellular activation. However, the role of antibodies with low affinity in blocking allergen activity has not been studied in detail. Because (Fig 2, A) . These data suggest that the inhibitory effect of germline antibodies is not mediated through competition with IgE for binding to Fel d 1 but occurs primarily through engaging the inhibitory receptor FcgRIIb. The same results were obtained when mast cells were loaded with IgE F127 and incubated with either A044 germline or F127 germline antibody (Fig 2, B) . Again, the germline IgG 2a antibody sharing the same epitope as IgE F127 could not abrogate cell degranulation, whereas the A044 germline antibody could.
Inhibitory effect of germline IgG 2a in vitro is FcgRIIb dependent
To confirm that the inhibitory effect of germline A044 antibody is mediated through the inhibitory receptor FcgRIIb rather than through competition with IgE for binding to Fel d 1, a biological inhibitor (based on DARPin technology) of mouse FcgRIIb receptor was used for blocking the receptor. 15 As shown in Fig 3 , 50 mg/mL DARPin was sufficient to abrogate the inhibitory effect of both mature and germline IgG 2a A044 antibodies on IgE F127 antibody-loaded mast cells. In contrast, blocking FcgRIIb receptor had no effect on the neutralizing activity of mature IgG 2a F127 antibody. These results indicated that Fel d 1-specific germline IgG 2a -induced inhibition of BMMC degranulation is FcgRIIb dependent.
Fel d 1-specific germline IgG 2a antibody blocks mast cell activation in vivo
Having demonstrated that low-affinity germline antibodies can block mast cell activation in vitro, we next addressed whether this concept translates to the in vivo situation. BALB/c mice were injected with either A044 or F127 IgEs alone or along with mature A044, germline A044, mature F127, or germline (3, 30 , and 300 mg/mL) with mouse Fel d 1 dimer (3 mg/mL) for 1 hour. Naive BMMCs, which have not been treated with unspecific IgGs, were used as controls. The degree of BMMC degranulation was determined by measuring b-hexosaminidase release. Data shown are representative for 3 independent experiments. *P < _ .05 and **P < _ .01. ns, Not significant. A044 antibody efficiently prevented mast cell degranulation, whereas no inhibition was observed with germline A044 antibody (Fig 4, B) . Using a similar IgG setup but with sensitization with A044 and challenge with F127 confirmed these results as germline IgG 2a F127 antibodies with the same epitope did not display any inhibition of mast cell degranulation. In contrast germline IgG 2a A044 antibody with a different specificity successfully prevented degranulation (Fig 5, B) .
To further confirm the inhibitory capacity of the germline IgG 2a A044 antibody in IgE F127-induced mast cell activation, a dose-response experiment was performed. To this end, mice were sensitized with IgE F127 antibody together with different doses of IgG 2a A044 germline antibody. As shown in Fig E5 in this article's Online Repository at www.jacionline.org, strong mast cell degranulation was observed in mice injected with IgE F127 antibody alone and inhibition by IgG 2a A044 germline antibody occurred in a dose-dependent manner.
DARPin against mouse FcgRIIb was used for blocking the receptor by means of local subcutaneous injection into the ears of mice before prick tests to elucidate the mechanisms of germline IgG 2a antibody-mediated inhibition of mast cell degranulation in vivo. As mentioned above, coadministration of IgG 2a of a second specificity (no matter whether germline or mature antibodies were used) efficiently prevented mast cell degranulation in BALB/c mice (Figs 4, B, and 5, B) , whereas no IgG-dependent inhibition of mast cell degranulation was Quantification of mast cell degranulation was determined by the degree of dye extravasation measured at an OD of 595 nm after digestion of the ears. B, Severe mast cell degranulation was observed in the mice loaded with only IgE F127 antibody but much weaker when IgE F127 antibody was loaded together with IgG 2a A044 mature (M), A044 germline (GL), or F127 mature antibody. However, the combination of IgE F127 and F127 germline antibodies did not show lower degranulation ratio compared with other groups. C, Mast cell degranulation was observed in mice loaded with IgE F127 antibody plus DARPin and was inhibited only when loaded together with IgG 2a F127 mature antibody plus DARPin. IgG 2a A044 germline and A044 antibody-induced inhibition were all abolished on local DARPin treatment. Dye was extracted from collected ears by means of digestion with KOH overnight at 378C. After full digestion, H 3 PO 4 was added, and supernatants were collected and measured at an OD of 595 nm to for quantification. Results show means 6 SEMs of OD595, and data shown are representative for 5 independent experiments. *P < _ .05 and **P < _ .01. ns, Not significant. To better mimic the physiologic situation and directly assess whether germline IgG 2a antibody mediated inhibition of systematic allergic reaction in vivo is FcgRIIb dependent, mice were passively sensitized with Fel d 1-specific IgE A044 antibody with or without IgG 2a (A044 or germline A044 or F127 or germline F127 antibodies) combined with or without AT128 mAb against mouse FcgRIIb receptor by means of intravenous injection. Fel d 1 challenge was performed 12 hours after sensitization. In accordance with in vivo results from passive cutaneous anaphylaxis, coadministration of IgG 2a of a second specificity (both germline and mature antibodies) could dramatically alleviate the systematic anaphylaxis (core temperature decrease) in BALB/c mice (see Fig E6, B, in this article's Online Repository at www.jacionline.org), whereas no IgG-dependent relief of systematic anaphylaxis was observed when FcgIIb was blocked by mAb AT128 (see Fig E6, B) . These results confirmed again that Fel d 1-specific germline IgG 2a -induced inhibition of allergic reaction is FcgRIIb dependent.
In summary, when IgE-induced mast cell degranulation is blocked by engaging the inhibitory receptor, the affinity of IgGs is less important compared with that of IgGs compared with IgE by a classical neutralization mechanism. Thus low-affinity antibodies do not neutralize the allergen but block mast cell activation through FcgRIIb.
DISCUSSION
Allergen-specific IgG antibodies are induced during SIT and correlate with protection against allergic symptoms. IgG B, Severe mast cell degranulation was observed in mice loaded with only IgE A044 and IgE A044 plus IgG 2a A044 germline (GL) antibodies but was much weaker when IgE A044 antibody was loaded together with IgG 2a A044 mature (M), F127 germline, or F127 mature antibodies. C, Mast cell degranulation was observed in mice loaded with IgE A044 antibody plus DARPin and inhibited only when loaded together with IgG 2a A044 mature antibody plus DARPin. IgG 2a F127 and F127 germline antibody-induced inhibition was all abolished on local DARPin treatment. Dye was extracted from collected ears by means of digestion with KOH overnight at 378C. After full digestion, H 3 PO 4 was added, and supernatants were collected and measured at an OD of 595 nm for quantification. Results show means 6 SEMs of OD595, and data shown are representative for 5 independent experiments. **P < _ .01 and ***P < _ .001. ns, Not significant.
antibodies block mast cell activation either by simply neutralizing the allergen or by engaging the inhibitory FcgRIIb. 17 Here we demonstrate that the 2 mechanisms are governed by different affinity thresholds.
SIT has been shown to induce high-affinity blocking antibodies with somatic mutations in their complementarity-determining region as an indication for affinity maturation. [10] [11] [12] [13] [14] [15] [16] [17] [18] These findings are recapitulated here because high-affinity Fel d 1-specific antibodies induced by immunizing mice with Fel d 1 coupled to Qb-derived virus-like particles showed a high degree of hypermutation, and affinity was dramatically lower on back-mutation of the variable regions to germline sequences. Despite vastly different affinities, the germline antibodies exhibited the same epitope specificity as the parental antibodies; indeed, somatic hypermutation usually does not change the epitopes recognized. This allowed us to compare the importance of antibody affinity without interference by a difference in antibody specificity. Using this system, we found that the allergen-neutralizing pathway was strongly dependent on affinity because germline sequence antibodies did not block mast cell activation either in vitro or in vivo. In contrast, the inhibitory FcgRIIb pathway was independent of affinity because low-affinity antibodies were similarly effective as high-affinity antibodies.
In contrast to the mouse, in human subjects only the presence of FcgRIIb on the basophil surface is well documented, 7 but the presence of FcgRIIb on mast cells remains unclear.
19,20 Thus the described mechanism will likely occur in human basophils, but its importance in human mast cells requires more detailed investigation. Furthermore, because IgA antibodies do not bind to the FcgRIIb our results might only apply to IgG and not IgA antibodies.
The described findings support the mechanistic hypothesis that allergen neutralization is best described by a model analogous to competitive inhibition in enzymology, whereas the inhibitory pathway follows a noncompetitive model. 21 From a clinical perspective, this might explain why SIT based on allergoids is remarkably effective, even though many of the allergen epitopes are slightly denatured because of their chemical modification. 22 Our results might explain these findings because low-affinity antibodies appear to be clinically more important than previously assumed. Indeed, it is known that allergies are often caused by cross-reactive IgE antibodies that recognize a number of different allergens generated by vastly different species. 23, 24 One would expect that allergen-neutralizing IgG antibodies have a similar cross-reactivity pattern. 7, 21, 25 However, our data suggest that IgG antibodies triggering the inhibitory FcgRIIb pathway show an even broader cross-reactivity pattern because of the lower affinity-threshold. 19 Therefore SIT can generate a protective umbrella of inhibitory IgG antibodies that is larger than previously thought. (Fig E4, A) or Fel d 1 dimer (Fig E4,  B) of a series of 5 antibody concentrations (starting for mature antibodies at 100 nmol/L and for germline antibodies at 2500 nmol/L). Each curve was globally fit (black lines) in a kinetic model at 1:1 binding. C, Sensorgrams of binding of A044 germline at different concentrations (500 nmol/L to 31.25 nmol/L) to either Fel d 1 monomer or dimer directly immobilized on the CM5 chip. Each curve were globally fit (black lines) in a 1:1 interaction model.
FIG E5.
Germline mAb IgG 2a A044 but not F127 inhibited IgE F127-induced mast cell activation in vivo in a dose-dependent manner. A, Ear prick scheme to determine mast cell degranulation in vivo. Mice were given intravenous (i.v.) injections of 10 mg of mouse IgE F127 and/or IgG 2a germline A044 antibodies (10, 50, and 100 mg). Twenty-four hours later, each mouse was injected with 200 mL of Evans blue dye intravenously and challenged with 20 mg of Fel d 1 dimer on the outer ear skin 25 minutes later. Quantification of mast cell degranulation was determined by the degree of dye extravasation measured at an OD of 595 nm after digestion of ears. B, strong mast degranulation was observed in the mice loaded with IgE F127 antibody and was inhibited in combination of IgG 2a germline A044 antibody in a dose-dependent manner. C, Dye was extracted from collected ears by means of digestion with KOH overnight at 378C. After full digestion, H 3 PO 4 was added, and supernatants were collected and measured at an OD of 595 nm for quantification. Results show means 6 SEMs of OD595, and data shown are representative for 5 independent experiments. *P < _ .05 and **P < _ .01. ns, Not significant.
FIG E6.
Low-affinity germline mAbs inhibit IgE A044-induced passive systematic anaphylaxis in vivo through blocking FcgRIIb. A, Scheme of passive systematic anaphylaxis to determine mast cell degranulation in vivo. Mice were passively sensitized with 10 mg of Fel d 1-specific IgE A044 by means of intravenous (i.v.) tail vain injection. The next day, either 100 mg of IgG 2a (A044 or A044 germline or F127 or F127 germline antibodies) or 100 mg of IgG 2a combined with AT128 mAb against mouse FcgRIIb receptor were injected intravenously. After 24 hours, mice were challenged by means of intravenous injection of 5 mg of Fel d 1. Core body temperature was measured immediately before and every 10 minutes after antigen challenge for 60 minutes. B, A strong decrease in core body temperature was observed in mice loaded with IgE A044 alone and IgE A044 combined with IgG 2a A044 germline (GL) but was inhibited in combination of IgG 2a F127 germline/F127 mature (M)/A044 mature. However, inhibition of systematic anaphylaxis induced by F127 germline/F127 mature was abolished on administration of AT128 mAb against mouse FcgRIIb receptor. Results show means 6 SEMs of temperatures, and data shown are representative for 5 independent experiments. *P < _ .05, **P < _ .01, ***P < _ .001, and ****P < _ .0001. ns, Not significant.
